产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20520 | 4,5-二碘-2-甲基-1,2,3三氮唑 | 859790-39-9 | 98% Min. |  |
| 20521 | 4,5-二碘-1H-1H-1,2,3-三氮唑 | 28194-09-4 | 98% Min. |  |
| 20522 | (S)-5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol | 2921961-53-5 | 98% Min. | -5-fluoro-3-methylbenzo[c][1,2]oxaborol-1(3H)-ol_2921961-53-5.png) |
| 20523 | 1-乙基-1H-吡唑-4-甲醛 | 304903-10-4 | 98% Min. |  |
| 20543 | (1S,5S)-1-(羟甲基)-3-氮杂双环[3.1.0]己烷-3-羧酸叔丁酯 | 1932534-25-2 | 98% Min. | -1-(hydroxymethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate_1932534-25-2.png) |
| 20576 | STX-721 | 2765525-82-2 | ≧98.0% |  |
| STX-721 is a next-generation, orally delivered therapy, designed with potential best- | ||||
| 20577 | LY-3522348 | 2568608-48-8 | ≧98.0% |  |
| LY-3522348是一种酮己糖激酶（KHK）抑制剂. | ||||
| 20594 | JTE-151 | 1404380-58-0 | ≧98.0% |  |
| JTE-151 是一种 RORγ 抑制剂，可通过抑制与 Th17 细胞活化相关的 ROR | ||||
| 20608 | Ninerafaxstat | 2254741-41-6 | ≧98.0% |  |
| Ninerafaxstat is a biochemical that decreases fatty acid oxidation and improves mitoc | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 20625 | Orismilast ( LEO-32731 ) | 1353546-86-7 | ≧98.0% |  |
| Orismilast是一种磷酸二酯酶4型（PDE4）抑制剂。 | ||||
| 20639 | SOP1812 (QN-302) | 2546091-70-5 | ≧98.0% | _2546091-70-5.png) |
| QN-302 是一种 G4选择性转录抑制剂。 | ||||